IL1-β expression in multiple sclerosis

被引：7
|
作者：
Maghzi, Amir Hadi [1 ]
Minagar, Alireza [2 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[2] LSU Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71130 USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2014年 / 343卷 / 1-2期
关键词：
IRAN; ISFAHAN;
D O I：
10.1016/j.jns.2014.05.009
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [21] Conjugal multiple sclerosis in Isfahan, Iran: a population-based study
    Maghzi, A. H.
    Etemadifar, M.
    Shaygannejad, V.
    Saadatnia, M.
    Salehi, M.
    Hassanzadeh, A.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (05) : 673 - 675
  • [22] Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran
    Maghzi, A. H.
    Etemadifar, M.
    Saadatnia, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (04) : 403 - 407
  • [23] Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran
    Etemadifar, M.
    Mehrabi, B.
    Kiani-Peykani, R.
    Abtahi, S. -H.
    Nekouie-Isfahani, K.
    Ramagopalan, S. V.
    Fereidan-Esfahani, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 134 (04): : 292 - 299
  • [24] Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease
    Hosseini, Arezoo
    Babaloo, Zohreh
    Gharibi, Tohid
    Shomali, Navid
    Marofi, Faroogh
    Hashemi, Vida
    Ayromlou, Hormoz
    Asadi, Milad
    Rahmani, Shima
    Noorolyai, Saeed
    Shanehbandi, Dariush
    Baradaran, Behzad
    BMC RESEARCH NOTES, 2020, 13 (01)
  • [25] Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease
    Arezoo Hosseini
    Zohreh Babaloo
    Tohid Gharibi
    Navid Shomali
    Faroogh Marofi
    Vida Hashemi
    Hormoz Ayromlou
    Milad Asadi
    Shima Rahmani
    Saeed Noorolyai
    Dariush Shanehbandi
    Behzad Baradaran
    BMC Research Notes, 13
  • [26] Intercellular adhesion molecule-1 gene polymorphism in Iranian patients with multiple sclerosis
    Mousavi, S. A. R.
    Nikseresht, A. R.
    Arandi, N.
    Borhani-Haghighi, A.
    Ghaderi, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (12) : 1397 - 1399
  • [27] Prevalence of multiple sclerosis in Isfahan, Iran
    Etemadifar, Masoud
    Janghorbani, Mohsen
    Shaygannejad, Vahid
    Ashtari, Fereshteh
    NEUROEPIDEMIOLOGY, 2006, 27 (01) : 39 - 44
  • [28] Biosimilars in Treatment of Multiple Sclerosis in Iran
    Moghadasi, Abdorreza Naser
    ARCHIVES OF IRANIAN MEDICINE, 2021, 24 (10) : 779 - 782
  • [29] Economic Burden of Multiple Sclerosis Drugs in Iran during 2011-2019
    Asadollahi, Mina
    Darvishi, Ali
    Azimi, Amirreza
    Annabi, Majid
    Jafariazar, Zahra
    Heshmat, Ramin
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2023, 52 (02) : 407 - 419
  • [30] Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
    Salehi, Zahra
    Almasi-Hashiani, Amir
    Sahraian, Mohammad Ali
    Ashtari, Fereshteh
    Baghbanian, Seyed Mohammad
    Razazian, Nazanin
    Moghadasi, Abdorreza Naser
    Bayati, Asghar
    Azimi, Amir Reza
    Beladimoghadam, Nahid
    Harirchian, Mohammad Hossein
    Poursadeghfard, Maryam
    Navardi, Samira
    Shirkoohi, Reza
    Heidari, Hora
    Ghaffari, Mehran
    Eskandarieh, Sharareh
    BMC NEUROLOGY, 2022, 22 (01)
12345